Log in to save to my catalogue

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8523009

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
The inflammatory cascade is the main cause of death in COVID-19 patients. Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which patients to administer it remains undefined.
Objective
We aimed to evaluate the efficacy of immunosuppressive/anti-inflammatory therapy in COVID-19, based on the de...

Alternative Titles

Full title

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8523009

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8523009

Other Identifiers

ISSN

0884-8734

E-ISSN

1525-1497

DOI

10.1007/s11606-021-07146-0

How to access this item